KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Inventory Average: 2019-2025

Historic Inventory Average for Castle Biosciences (CSTL) over the last 6 years, with Sep 2025 value amounting to $8.5 million.

  • Castle Biosciences' Inventory Average rose 16.67% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 16.67%. This contributed to the annual value of $8.0 million for FY2024, which is 34.85% up from last year.
  • Latest data reveals that Castle Biosciences reported Inventory Average of $8.5 million as of Q3 2025, which was up 11.84% from $7.6 million recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Inventory Average peaked at $8.5 million during Q3 2025, and registered a low of $2.2 million during Q1 2022.
  • Its 3-year average for Inventory Average is $6.9 million, with a median of $7.4 million in 2024.
  • As far as peak fluctuations go, Castle Biosciences' Inventory Average spiked by 94.46% in 2023, and later fell by 3.87% in 2025.
  • Quarterly analysis of 5 years shows Castle Biosciences' Inventory Average stood at $2.2 million in 2021, then skyrocketed by 77.02% to $3.9 million in 2022, then surged by 76.19% to $6.9 million in 2023, then rose by 7.26% to $7.4 million in 2024, then rose by 16.67% to $8.5 million in 2025.
  • Its last three reported values are $8.5 million in Q3 2025, $7.6 million for Q2 2025, and $7.5 million during Q1 2025.